Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-004779
Filing Date
2019-01-22
Accepted
2019-01-22 17:09:18
Documents
1
Period of Report
2019-01-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6257
  Complete submission text file 0001209191-19-004779.txt   7802
Mailing Address 550 HAMILTON AVENUE, SUITE 100 PALO ALTO CA 94301
Business Address
Topper James N (Reporting) CIK: 0001341382 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 19535924

Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations